These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 15651435)

  • 1. Treating traumatic bleeding in a combat setting: possible role of recombinant activated factor VII.
    Martinowitz U; Zaarur M; Yaron BL; Blumenfeld A; Martonovits G
    Mil Med; 2004 Dec; 169(12 Suppl):16-8, 4. PubMed ID: 15651435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treating traumatic bleeding in a combat setting.
    Clifford CC
    Mil Med; 2004 Dec; 169(12 Suppl):8-10, 4. PubMed ID: 15651433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring of hemostasis in combat trauma patients.
    Carr ME
    Mil Med; 2004 Dec; 169(12 Suppl):11-5, 4. PubMed ID: 15651434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cellular basis of traumatic bleeding.
    Hoffman M
    Mil Med; 2004 Dec; 169(12 Suppl):5-7, 4. PubMed ID: 15651432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood transfusion management in the severely bleeding military patient.
    Gurney JM; Spinella PC
    Curr Opin Anaesthesiol; 2018 Apr; 31(2):207-214. PubMed ID: 29470190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of recombinant activated factor VII on mortality in combat-related casualties with severe trauma and massive transfusion.
    Spinella PC; Perkins JG; McLaughlin DF; Niles SE; Grathwohl KW; Beekley AC; Salinas J; Mehta S; Wade CE; Holcomb JB
    J Trauma; 2008 Feb; 64(2):286-93; discussion 293-4. PubMed ID: 18301188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical adjuncts to noncompressible torso hemorrhage as tools for patient blood management.
    Rappold JF; Bochicchio GV
    Transfusion; 2016 Apr; 56 Suppl 2():S203-7. PubMed ID: 27100757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemorrhage control in the battlefield: role of new hemostatic agents.
    Alam HB; Burris D; DaCorta JA; Rhee P
    Mil Med; 2005 Jan; 170(1):63-9. PubMed ID: 15724857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Massive transfusion and nonsurgical hemostatic agents.
    Perkins JG; Cap AP; Weiss BM; Reid TJ; Bolan CD
    Crit Care Med; 2008 Jul; 36(7 Suppl):S325-39. PubMed ID: 18594260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of recombinant factor VIIa in US military casualties for a five-year period.
    Wade CE; Eastridge BJ; Jones JA; West SA; Spinella PC; Perkins JG; Dubick MA; Blackbourne LH; Holcomb JB
    J Trauma; 2010 Aug; 69(2):353-9. PubMed ID: 20699744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of recombinant factor VIIA for control of combat-related haemorrhage.
    Woodruff SI; Dougherty AL; Dye JL; Mohrle CR; Galarneau MR
    Emerg Med J; 2010 Feb; 27(2):121-4. PubMed ID: 20156864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of topical hemostatic agents for combat wound treatment.
    Kheirabadi B
    US Army Med Dep J; 2011; ():25-37. PubMed ID: 21607904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of a Golden Hour Policy on the Morbidity and Mortality of Combat Casualties.
    Kotwal RS; Howard JT; Orman JA; Tarpey BW; Bailey JA; Champion HR; Mabry RL; Holcomb JB; Gross KR
    JAMA Surg; 2016 Jan; 151(1):15-24. PubMed ID: 26422778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of recombinant activated factor VII in securing haemostatic failure in gun shot trauma.
    Shamsi T; Tufail M; Aftab M; Ansari S
    J Pak Med Assoc; 2006 May; 56(5):238-41. PubMed ID: 16767955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does prehospital fluid administration impact core body temperature and coagulation functions in combat casualties?
    Farkash U; Lynn M; Scope A; Maor R; Turchin N; Sverdlik B; Eldad A
    Injury; 2002 Mar; 33(2):103-10. PubMed ID: 11890910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The incidence of thromboembolism formation following the use of recombinant factor VIIa in patients suffering from blunt force trauma compared with penetrating trauma: a systematic review.
    Devlin R; Bonanno L; Badeaux J
    JBI Database System Rev Implement Rep; 2016 Mar; 14(3):116-38. PubMed ID: 27532142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two Decades of Saving Lives on the Battlefield: Tactical Combat Casualty Care Turns 20.
    Butler FK
    Mil Med; 2017 Mar; 182(3):e1563-e1568. PubMed ID: 28290925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UK defence medical services guidance for the use of recombinant factor VIIa (rFVIIa) in the deployed military setting.
    Hodgetts TJ; Kirkman E; Mahoney PF; Russell R; Thomas R; Midwinter M
    J R Army Med Corps; 2007 Dec; 153(4):307-9. PubMed ID: 18619169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of recombinant-activated factor VII in bleeding trauma patients.
    Dutton RP; Conti BM
    Curr Opin Anaesthesiol; 2009 Apr; 22(2):299-304. PubMed ID: 19295430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of the CONTROL trial: efficacy and safety of recombinant activated Factor VII in the management of refractory traumatic hemorrhage.
    Hauser CJ; Boffard K; Dutton R; Bernard GR; Croce MA; Holcomb JB; Leppaniemi A; Parr M; Vincent JL; Tortella BJ; Dimsits J; Bouillon B;
    J Trauma; 2010 Sep; 69(3):489-500. PubMed ID: 20838118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.